Signaling Pathways - SERT - DOT1L - EZH2
清除全部
- B4678 CPI-1691 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- B1581 EPZ004777 HClTarget: DOT1LSummary: DOT1L抑制剂
- B1583 UNC19992 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- A3926 Vortioxetine中文名: 沃替西汀Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERTSummary: 5-HT受体拮抗剂
- A3449 GSK3431 CitationTarget: EZH2Summary: EZH2抑制剂
- A3446 GSK1265 CitationTarget: EZH2Summary: EZH2抑制剂
- A4170 EPZ004777Target: DOT1LSummary: DOT1L抑制剂
- A4171 EPZ0056872 CitationTarget: EZH2Summary: EZH2抑制剂
- A4166 EPZ56761 CitationTarget: DOT1LSummary: DOT1L抑制剂
- A8182 3-Deazaneplanocin A (DZNep) hydrochloride1 Citation中文名: 3-去氮腺嘌呤A盐酸盐Target: EZH2Summary: SAHH和EZH2抑制剂